343 related articles for article (PubMed ID: 35037412)
1. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
Durrani IA; Bhatti A; John P
PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
[TBL] [Abstract][Full Text] [Related]
6. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
7. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
10. Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis.
Yu F; Pan XJ; Luo J
Dis Markers; 2022; 2022():9041466. PubMed ID: 35686034
[TBL] [Abstract][Full Text] [Related]
11. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
[No Abstract] [Full Text] [Related]
12. Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools.
Oumeddour A
Medicine (Baltimore); 2023 Mar; 102(11):e33291. PubMed ID: 36930083
[TBL] [Abstract][Full Text] [Related]
13. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
15. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
[TBL] [Abstract][Full Text] [Related]
17. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses.
Liu D; Zhang J; Li L; Wang Q; Lan Y
J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094
[TBL] [Abstract][Full Text] [Related]
18. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis.
Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y
Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689
[TBL] [Abstract][Full Text] [Related]
20. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]